Brief: Organovo And Tarveda Therapeutics Announce Definitive Merger Agreement

VivoSim Labs

16/12/2019 12:05

Dec 16 (Reuters) - Organovo Holdings Inc  ONVO.O :
    * ORGANOVO AND TARVEDA THERAPEUTICS ANNOUNCE DEFINITIVE
MERGER
AGREEMENT
    * ORGANOVO HOLDINGS INC - COMBINED COMPANY TO OPERATE AS
TARVEDA
THERAPEUTICS UPON CLOSING OF MERGER
    * ORGANOVO HOLDINGS INC - TARVEDA WOULD MERGE WITH A
WHOLLY-OWNED
SUBSIDIARY OF ORGANOVO IN AN ALL-STOCK TRANSACTION
    * ORGANOVO HOLDINGS - UNDER TERMS OF MERGER, IT IS
ANTICIPATED
THAT TARVEDA STOCKHOLDERS WILL OWN ABOUT 75% OF COMBINED CO
    * ORGANOVO HOLDINGS - UPON COMPLETION OF MERGER, MERGED
COMPANY
WOULD TRADE ON NASDAQ STOCK MARKET LLC UNDER TICKER SYMBOL
"TVDA"
    * ORGANOVO- DEAL TO ADVANCE TARVEDA'S PROPRIETARY PENTARIN
MINIATURE DRUG CONJUGATES INCLUDING 2 CLINICAL PROGRAMS FOR
TREATMENT OF SOLID TUMOR MALIGNANCIES
    * ORGANOVO HOLDINGS - UNDER TERMS OF MERGER, ANTICIPATED
THAT
CURRENT ORGANOVO STOCKHOLDERS WILL OWN ABOUT 25% OF COMBINED CO
    * ORGANOVO HOLDINGS - TARVEDA EXPECTS MERGER TO PROVIDE
CAPITAL TO
ADVANCE TWO LEAD PROGRAMS THROUGH NEXT SET OF CLINICAL
MILESTONES, AMONG OTHER THINGS
    * ORGANOVO HOLDINGS- CORPORATE HEADQUARTERS OF COMBINED CO
WILL BE
LOCATED IN WATERTOWN, MA
    * ORGANOVO HOLDINGS - POST DEAL, COMBINED CO WILL BE LED BY
CURRENT TARVEDA MANAGEMENT TEAM
    * ORGANOVO HOLDINGS INC - BOARD OF COMBINED COMPANY WILL BE
COMPRISED OF 8 DIRECTORS, INCLUDING 6 TO BE NAMED BY TARVEDA AND
2 TO BE NAMED BY CO

Source text for Eikon:  ID:nBwbrt0DCa 
Further company coverage:  ONVO.O 

 ((Reuters.Briefs@thomsonreuters.com;))